Heartburn drug shows promise for sickle cell pain in kids
NCT ID NCT05084521
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 23 times
Summary
This study tested whether famotidine, a common heartburn medicine, can lower a blood marker linked to pain crises in children with sickle cell disease. Thirty children aged 1 to 17 took the drug for 29 days. The goal was to see if it reduces P-selectin, a protein involved in blood vessel blockages that cause pain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Necker - Enfants malades Hospital; Department of Pediatrics and Infectious Diseases
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.